Industries de la santé
Hepatitis C market to see steady decline as high cure rates in major markets curb patient populations
08 Février 2017
The hepatitis C market is set to experience a steady decline, falling from $21.7 billion in 2015 to $17.5 billion by 2025, representing a negative compound annual growth rate of 2.1%, according to research and consulting firm GlobalData. |The company’s report states that this deterioration in sales, which will occur across the nine major markets (9MM) of the US, France, Germany, Italy...
Plus d'articles...
- Almost three-quarters of healthcare companies will invest in Big Data by 2021
- ReachBio Research Labs Launches a New Drug Development Platform, cellPrism®
- Edelris Announces Research Collaboration Agreement with Pfizer Inc.
- GenSight Biologics obtient la désignation de médicament orphelin aux Etats-Unis pour GS030 dans la rétinopathie pigmentaire